Inhibition of miR-96 enhances the sensitivity of colorectal cancer cells to oxaliplatin by targeting TPM1

Colorectal cancer (CRC) is one of the major threats to human health worldwide. In the treatment of CRC, chemoresistance affects the efficacy of platinum-based therapies. Oxaliplatin is one of the most commonly used first-line medications for the treatment of CRC; however, chemoresistance is common a...

Full description

Saved in:
Bibliographic Details
Published in:Exp Ther Med
Main Authors: Ge, Tingrui, Xiang, Ping, Mao, Haibing, Tang, Shumin, Zhou, Jinyi, Zhang, Yonggang
Format: Artigo
Language:Inglês
Published: D.A. Spandidos 2020
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7401935/
https://ncbi.nlm.nih.gov/pubmed/32765688
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2020.8936
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items